Sub-family selective actions in the ability of Erk2 MAP kinase to phosphorylate and regulate the activity of PDE4 cyclic AMP-specific phosphodiesterases-Reference-Cited by-同舟云学术

Sub-family selective actions in the ability of Erk2 MAP kinase to phosphorylate and regulate the activity of PDE4 cyclic AMP-specific phosphodiesterases

Published:2000-10 Issue:4 Volume:131 Page:811-819
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Baillie George S,MacKenzie Simon J,McPhee Ian,Houslay Miles D

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/sj.bjp.0703636/fullpdf

Reference63 articles.

1. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells;AHMAD;J. Immunol.,1999

2. Pro-Leu-Ser/Thr-Pro is a consensus primary sequence for substrate protein phosphorylation: characterization of the phosphorylation of c-myc and c-jun proteins by an epidermal growth factor receptor threonine 669 protein kinase;ALVAREZ;J. Biol. Chem.,1991

3. Activation and selective inhibition of a cyclic AMP-specific phosphodiesterase, PDE-4D3;ALVAREZ;Mol. Pharmacol.,1995

4. UCR1 and UCR2 domains unique to the cAMP-specific phosphodiesterase (PDE4) family form a discrete module via electrostatic interactions;BEARD;J. Biol. Chem.,2000

5. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms;BEAVO;Physiol. Rev.,1995

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phosphodiesterase 4 is overexpressed in keloid epidermal scars and its inhibition reduces keratinocyte fibrotic alterations;Molecular Medicine;2024-09-02

2. PDE4D: A Multipurpose Pharmacological Target;International Journal of Molecular Sciences;2024-07-24

3. Therapeutic perspectives on PDE4B inhibition in adipose tissue dysfunction and chronic liver injury;Expert Opinion on Therapeutic Targets;2024-06-19

4. Beta‐amyloid interacts with and activates the long‐form phosphodiesterase PDE4D5 in neuronal cells to reduce cAMP availability;FEBS Letters;2024-05-09

5. Phosphodiesterases in heart and vessels- From Physiology to Diseases;Physiological Reviews;2023-11-16